SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021282
Filing Date
2017-11-02
Accepted
2017-11-02 17:03:19
Documents
75
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jnp-10q_20170930.htm 10-Q 2472574
2 EX-10.1 jnp-ex101_691.htm EX-10.1 168296
3 EX-10.2 jnp-ex102_690.htm EX-10.2 384285
4 EX-10.3 jnp-ex103_689.htm EX-10.3 143437
5 EX-31.1 jnp-ex311_6.htm EX-31.1 8776
6 EX-31.2 jnp-ex312_15.htm EX-31.2 8718
7 EX-32.1 jnp-ex321_8.htm EX-32.1 5826
8 EX-32.2 jnp-ex322_9.htm EX-32.2 6083
9 GRAPHIC g201711021625553652458.jpg GRAPHIC 779
  Complete submission text file 0001564590-17-021282.txt   8910389

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT jnp-20170930.xml EX-101.INS 1932924
11 XBRL TAXONOMY EXTENSION SCHEMA jnp-20170930.xsd EX-101.SCH 47520
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jnp-20170930_cal.xml EX-101.CAL 60046
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnp-20170930_def.xml EX-101.DEF 162427
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnp-20170930_lab.xml EX-101.LAB 354425
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnp-20170930_pre.xml EX-101.PRE 280437
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 171173346
SIC: 2834 Pharmaceutical Preparations